ANALYTICAL TESTING LABORATORIES FOR THE 128431686

The Jammu Kashmir Health Medical Education Department has published a tender for "ANALYTICAL TESTING LABORATORIES FOR THE TEST AND ANALYSIS OF DRUGS, MEDICINES, SURGICAL and SUTURES FOR THE YEAR 2025-27" on the 29 Sep 2025. This tender belongs to Drug Analysis Laboratories category. This tender is published in Jammu, Jammu and Kashmir location. The vendors interested in this tender and related Drug Analysis Laboratories tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.
Related alert: medicine testing Tenders | healthcare services Tenders | medical equipment testing Tenders
Related categories: Bacteriological laboratory service Tenders | Biological laboratory service Tenders | Pathology Lab Services Tenders |

Did You Know?

In Jammu district, Jammu and Kashmir, a total of 2 Drug Analysis Laboratories tenders have been published, with 1 tenders released last quarter.

🔔 View All Similar Tenders
🚀 Unlock Latest Indian Government Tenders — Free Updated daily with verified government procurement notices.
Tender Details
 Tender Title / Description
Tender Title ANALYTICAL TESTING LABORATORIES FOR THE TEST AND ANALYSIS OF DRUGS, MEDICINES, SURGICAL and SUTURES FOR THE YEAR 2025-27
Tender Description intra lipid injection 10%. irinotecaninj. ip/usp100mg/5ml  inj. zuclopenthixol long action 200mg/ml inj. mivacurium chloride 2mg/ml inj. mitomycin-c 2mg, single dose vial buprenorphine transdermal patch 5mcg, patches  buprenorphine transdermal patch 10mcg, patches  buprenorphine transdermal patch 20mcg, patches  inj. liposomal doxirobucin 20mg/10ml, vial  inj. liposomal doxirobucin 50mg/25ml, vial  tagafur + gimeracil + oteracil, cap. 20mg+5.8mg+15.8mg tagafur + gimeracil + oteracil, cap. 15mg+4.35mg+11.8mg inj. alteplase ep 20mg, vial  inj. alteplase ep 50mg, vial  inj. cangrelor 50mg/vial  inj. human prothrombincomplex ip 250mg, vial  axitinib tab. 5mg inj. reteplase 18mg, kit  inj. fosnetupitant + palonosetron 235mg + 0.25mg/vial, vial(20ml)  triple chamber peripheral parenteral nutrition bag with olive oil, 1 ltr bag  ipilimumab injection 50mg/ 10 ml inj. avelumab 200mg/10ml, vial  inj. fulvestrant 250mg/5ml, vial/pfs  clv injection lotion mometasone furoate usp 0.1% w/v, 30ml bott
Comments intra lipid injection 10%. irinotecaninj. ip/usp100mg/5ml  inj. zuclopenthixol long action 200mg/ml inj. mivacurium chloride 2mg/ml inj. mitomycin-c 2mg, single dose vial buprenorphine transdermal patch 5mcg, patches  buprenorphine transdermal patch 10mcg, patches  buprenorphine transdermal patch 20mcg, patches  inj. liposomal doxirobucin 20mg/10ml, vial  inj. liposomal doxirobucin 50mg/25ml, vial  tagafur + gimeracil + oteracil, cap. 20mg+5.8mg+15.8mg tagafur + gimeracil + oteracil, cap. 15mg+4.35mg+11.8mg inj. alteplase ep 20mg, vial  inj. alteplase ep 50mg, vial  inj. cangrelor 50mg/vial  inj. human prothrombincomplex ip 250mg, vial  axitinib tab. 5mg inj. reteplase 18mg, kit  inj. fosnetupitant + palonosetron 235mg + 0.25mg/vial, vial(20ml)  triple chamber peripheral parenteral nutrition bag with olive oil, 1 ltr bag  ipilimumab injection 50mg/ 10 ml inj. avelumab 200mg/10ml, vial  inj. fulvestrant 250mg/5ml, vial/pfs  clv injection lotion mometasone furoate usp 0.1% w/v, 30ml bott
 Important Dates
Published Date
Due Date 28 Oct 2025 00:00:00
 Estimate and EMD
Estimated Value 0.0
EMD 0 INR
Processing Fee 0 INR
 Document Links
 Purchasing Agency
 Tender No

TSID: 128431686

 Tender Type and Location
Tender Category
Tender Type
WhatsApp Chat